| 2020 | 2021 | 2022 | 2023 (projected) | Receivables | 1.17 B | 1.41 B | 1.26 B | 1.05 B | Inventories | 830 M | 1.04 B | 1.19 B | 1.09 B |
Reasons Agilent Technologies (USA Stocks:A) can excite investors
 | By Nico Santiago | Macroaxis Story |
Agilent Technologies, a prominent player in the Healthcare sector and specifically in the Life Sciences Tools & Services category, has seen its stock (USA Stocks:A) surge over 4% despite a slight market downturn. This international/domestic company, listed on the NYSE, boasts a robust enterprise value of $37.7B and a market capitalization matching its enterprise value. Agilent's financial health is evident in its impressive operating margin of 25.11% and a profit margin of 19.19%. The company's EBITDA stands at a substantial $2.1B, further underlining its strong financial position. Agilent's gross profit is reported at $3.7B, and its net income from continuing operations is $1.3B, applicable to common shares. The company's revenue per share is $23.704, with total revenue reported at $7B. Agilent's income before tax is $1.5B, with a change to net income of $219M. Despite these impressive figures, the company is not without potential risks. The possible downside price is estimated at $125, according to analysts. Agilent Technologies has a dividend per share of $0.87, a testament to its commitment to rewarding its shareholders. The company's enterprise value revenue is 6.9195, and it has a CIK of 1.1M. According to 12 estimates from analysts, the highest estimated target price for Agilent's stock is $170. Despite the slight market downturn, Agilent Technologies continues to demonstrate its resilience and potential for growth. Agilent Technologies' Working Capital is projected to decrease significantly, based on the last few years of reporting. The Working Capital for the past year was at 1.73 billion. The current year's Receivables Turnover is expected to increase to 7.01, while the Net Income Per Employee is forecasted to decline to approximately $52.2K. Many of us are enthusiastic about the life sciences tools and services sector, making it worthwhile to examine Agilent Technologies. Despite the challenges, we remain optimistic about a swift recovery. In this article, I will also discuss various factors influencing Agilent Technologies' products and services, and explain how these may impact the company's investors.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Rifka Kats
Agilent Technologies, a prominent player in the Healthcare Equipment & Supplies industry, has seen its stock price surge over 4% despite a slight market downturn. The company, traded on the NYSE under the ticker A, has an impressive enterprise value of 37.7B, demonstrating its substantial market presence. Agilent's operating income stands at 1.6B, indicating a strong financial performance. The company's gross profit is an impressive 3.7B, further highlighting its profitability. Despite a total risk alpha of -0.31, indicating some level of risk, the company's earnings per share of 4.53 suggest that it could be a worthwhile investment. However, potential investors should also consider the company's income tax expense of 250M and a mean deviation of 1.1, which indicates a certain level of volatility in the stock's return.
A deeper look at Agilent
The average rating for the company is "Buy," as suggested by 12 analysts. Macroaxis provides advice on Agilent Technologies, serving to complement and cross-verify the current analyst consensus on Agilent Technologies. Our investment recommendation engine assesses the company's growth potential exclusively from the perspective of an investor's current risk tolerance and investment horizon.The performance of Agilent Technologies in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence Agilent Technologies' stock prices. When investing in Agilent Technologies, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, Agilent Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as Agilent Technologies carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.And What about dividends?
A dividend is the distribution of a portion of Agilent Technologies earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Agilent Technologies dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Agilent one year expected dividend income is about USD0.61 per share.
The current year's Dividends Paid is expected to grow to about 457.2 M. The current year's Dividend Yield is expected to grow to 0.01. | Last Reported | Projected for Next Year | ||
| Dividends Paid | 246.6 M | 457.2 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.24 | 0.30 | |
| Dividend Paid And Capex Coverage Ratio | 2.42 | 2.46 |
Investing in dividend-paying stocks, such as Agilent Technologies is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Agilent Technologies must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Agilent Technologies. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.How important is Agilent Technologies's Liquidity
Agilent Technologies financial leverage refers to using borrowed capital as a funding source to finance Agilent Technologies ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Agilent Technologies financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Agilent Technologies' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Agilent Technologies' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Agilent Technologies's total debt and its cash.
What do experts say about Agilent?
Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
Analysis ConsensusBreaking down Agilent Technologies Indicators
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Agilent Technologies has an asset utilization ratio of 65.12 percent. This suggests that the company is making $0.65 for each dollar of assets. An increasing asset utilization means that Agilent Technologies is more efficient with each dollar of assets it utilizes for everyday operations.
Agilent Technologies (A.US), a key player in the Healthcare Equipment & Supplies industry, has seen its stock surge over 4% despite a slight market downturn. This performance is noteworthy considering the company's operating margin of 0.25% and a five-year return of 0.73%. The company, which employs 18.4K full-time employees, has a net asset value of $10.52B and total debt of $2.77B.Agilent's current valuation stands at $37.68B, with an enterprise value of $37.7B. The company's price to book ratio is 8.63X, and it has a PE ratio of 28.1921. Despite a net interest income loss of $75M, the company has managed to maintain a healthy operating income of $1.6B and a net income from continuing operations of $1.3B. The company's EPS estimate for the current year is 5.5, with an EPS estimate of 5.98 for the next year. Agilent's revenue per share is 23.704, and it has a profit margin of 0.19%. Despite the market's volatility, Agilent Technologies continues to show strong performance, making it a potential consideration for investors in the healthcare sector. .
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Nico Santiago do not own shares of Agilent Technologies. Please refer to our Terms of Use for any information regarding our disclosure principles.